Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James M. Lonie
Observed names:
J. Lonie,
J.M. Lonie,
James M. Lonie,
James Lonie,
James Michael Lonie,
Lonie, James,
Lonie, James M.
show all 7
Institutions:
The University of Queensland,
Princess Alexandra Hospital,
Princess Alexandra Hospital
Observed institutions:
Queensland Health,
Translational Research Institute,
The University of Queensland,
Townsville Hospital,
Mater Misericordiae Hospital,
Princess Alexandra Hospital,
Sunshine Coast University Hospital,
Princess Alexandra Hospital
show all 8
ORCID:
0000-0002-0946-8238
Observed ORCID:
0000-0002-0946-8238
OpenAlex ID:
A5001696138
A meta-analysis of the prevalence of Low Anterior Resection Syndrome and systematic review of risk factors
2018
·
Alexander D. Croese
, James M. Lonie
, et al.
·
International Journal of Surgery
·
346
PDF
Mastery learning: how is it helpful? An analytical review
2017
·
Manjunath Siddaiah-Subramanya
, Sabin Smith
, et al.
·
Advances in Medical Education and Practice
·
58
PDF
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
2020
·
Lauren G. Aoude
, Vanessa F. Bonazzi
, et al.
·
Scientific Reports
·
35
PDF
ctDNA as a biomarker of progression in oesophageal adenocarcinoma
2022
·
V.F. Bonazzi
, L.G. Aoude
, et al.
·
ESMO Open
·
23
Circulating Tumor DNA
2023
·
Lauren G. Aoude
, Sandra Brosda
, et al.
·
Journal of Molecular Diagnostics
·
19
PDF
Prevalence of low anterior resection syndrome at a regional Australian centre
2018
·
Alexander D. Croese
, Omar N. Zubair
, et al.
·
ANZ Journal of Surgery
·
19
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy
2024
·
Sandra Brosda
, Lauren G. Aoude
, et al.
·
Genome Medicine
·
14
PDF
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank
2023
·
James M. Lonie
, Sandra Brosda
, et al.
·
Frontiers in Immunology
·
14
Understanding the immuno-biology of oesophageal adenocarcinoma: Towards improved therapeutic approaches
2021
·
James M. Lonie
, Andrew P. Barbour
, et al.
·
Cancer Treatment Reviews
·
12
PDF
Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma
2023
·
Clemence J. Belle
, James M. Lonie
, et al.
·
Frontiers in Immunology
·
11
PDF
Adrenal ganglioneuroblastoma in an adult
2017
·
James Lonie
, Rachael Boles
, et al.
·
ANZ Journal of Surgery
·
7
C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients
2023
·
Vanessa F. Bonazzi
, Lauren G. Aoude
, et al.
·
Asia-Pacific Journal of Clinical Oncology
·
6
PDF
Case report of rare cause of small bowel obstruction: distal migration of metal biliary stent requiring enterotomy
2024
·
William T. Rumble
, James M. Lonie
, et al.
·
International Surgery Journal
·
1
The impact of COVID-19 on colorectal cancer in regional Northern Australia and changes to treatment related to distance to care: a retrospective cohort study
2024
·
Richard Maguire
, Shaurya Jhamb
, et al.
·
Annals of Medicine and Surgery
·
1
The neoantigen and associated tumour microenvironment in long-term survivors with oesophageal adenocarcinoma
2026
·
James M. Lonie
, Sandra Brosda
, et al.
·
Frontiers in Immunology
PDF
Weakly Supervised Pathology-Informed Representation Learning for PET-Based Content Retrieval of Intra-Tumour Heterogeneity
2026
·
Vashistha, Rajat
, Brosda, Sandra
, et al.
·
arXiv (Cornell University)
PDF
Foundation Model Representation Learning for PET-based Prognostication
2026
·
Rajat Vashistha
, Sandra Brosda
, et al.
·
SSRN Electronic Journal
210. Development of Novel Immunotherapy-based Therapies in Oesophageal Adenocarcinoma by Harnessing Tumour Neoantigens
2025
·
James Lonie
, Sandra Brosda
, et al.
·
Diseases of the Esophagus
PDF
Harnessing tumour immune responses in oesophageal cancer: towards better personalised therapeutic strategies
2025
·
James Michael Lonie
Radiomics biomarkers are associated with survival in patients with Oesophageal Adenocarcinoma
2023
·
Lauren Aoude
, Bernadette Wong
, et al.
·
Research Square
PDF
1239P Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinoma
2022
·
L.G. Aoude
, V.F. Bonazzi
, et al.
·
Annals of Oncology
204. the Tumour Immune Microenvironment in Oesophageal Adenocarcinoma Has Prognostic Significance
2022
·
James Lonie
, Sandra Brosda
, et al.
·
Diseases of the Esophagus
Show more works
View as search
Works count:
27
Citation count:
567
H-index:
10
I10-index:
10
Year
Topic
Type
